Loading
GB
Genocea Biosciences, Inc. Stock: price and insider trades · United States
Genocea Biosciences, Inc.: what insiders have been doing
Genocea Biosciences, Inc. belongs to the Health Care sector. Filings by its managers are published through SEC (Form 4). The past year has been quiet: not a single insider filing for Genocea Biosciences, Inc. The previous disclosure was published on 3 June 2022.
These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Insider Decl.
30
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
€14,367
23 ops. · all time
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
as of FY 2021FY ended December 2021 · cache
US$0.00
Analyst consensus
Income statement
RevenueUS$1.6M
EBITDA-US$30.5M-1860% margin
Net income-US$33.2M-2022.9% margin
Valuation
P/Book0.0x
Beta38.68
Balance sheet & cash
Market capUS$5.9k
Total debtUS$17.2M
Free Cash Flow-US$48.7M
Debt / Equity125%
Profitability & ownership
ROE-525.8%
ROA-57.6%
% insiders0.0%
% institutions0.0%
Last declaration on 3 June 2022
Declarations30 total
1,355 shares@ US$0.062.6% of flowCommon StockSEC:0001457612-22-000075:0
4,023 shares@ US$0.064.8% of flowCommon StockSEC:0001457612-22-000073:0
1,578 shares@ US$0.063.1% of flowCommon StockSEC:0001457612-22-000074:0
2,500 shares@ US$0.0601100.0% of flowCommon StockSEC:0001457612-22-000070:0
117,244 shares@ €0.057558.9% of flowCommon StockSEC:0001457612-22-000069:0
20,425 shares@ US$0.0653100.0% of flowCommon StockSEC:0001457612-22-000066:0
24,407 shares@ US$0.076559.7% of flowCommon StockSEC:0001457612-22-000060:0
5,931,843 shares@ €0.0609100.0% of flowCommon StockSEC:0001209191-22-032330:0
5,931,843 shares@ €0.0609100.0% of flowCommon StockSEC:0001209191-22-032327:0
5,931,843 shares@ €0.0609100.0% of flowCommon StockSEC:0001209191-22-032322:0
16,525 shares@ US$0.088148.1% of flowCommon StockSEC:0001457612-22-000061:0
2,500 shares@ US$0.089100.0% of flowCommon StockSEC:0001457612-22-000062:0
5,931,843 shares@ €0.0609100.0% of flowCommon StockSEC:0001209191-22-032317:0
5,931,843 shares@ €0.0609100.0% of flowCommon StockSEC:0001209191-22-032329:0
5,931,843 shares@ €0.0609100.0% of flowCommon StockSEC:0001209191-22-032323:0
5,931,843 shares@ €0.0609100.0% of flowCommon StockSEC:0001209191-22-032331:0
5,931,843 shares@ €0.0609100.0% of flowCommon StockSEC:0001209191-22-032326:0
5,931,843 shares@ €0.0609100.0% of flowCommon StockSEC:0001209191-22-032320:0
3,924 shares@ US$1.2595.2% of flowCommon StockSEC:0001457612-22-000043:0
1,091 shares@ US$1.25100.0% of flowCommon StockSEC:0001457612-22-000044:0
1,212 shares@ US$1.2548.8% of flowCommon StockSEC:0001457612-22-000046:0
963 shares@ US$1.25100.0% of flowCommon StockSEC:0001457612-22-000042:0
963 shares@ US$1.2537.7% of flowCommon StockSEC:0001457612-22-000045:0
31,250 shares0Common StockSEC:0001457612-22-000028:0
37,500 shares0Common StockSEC:0001457612-22-000030:0
25 of 30 declarations
About Genocea Biosciences, Inc.
GENOCEA BIOSCIENCES, INC. is a biotechnology company focused on developing immunotherapies for infectious diseases and cancer. The company utilizes its vaccine discovery platform to identify unique immune targets.
